FTYCX
Price
$56.57
Change
-$0.05 (-0.09%)
Updated
Jul 31 closing price
Net Assets
12.15B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

FTYCX vs VSCIX

FTYCX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
FTYCX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTYCX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. FTYCX (12.1B). VSCIX pays higher dividends than FTYCX: VSCIX (1.23) vs FTYCX (0.00). FTYCX was incepted earlier than VSCIX: FTYCX (8 years) vs VSCIX (29 years). FTYCX (1.64) is less costly to investors than VSCIX (0.03). FTYCX is a more actively managed with annual turnover of: 28.00 vs. VSCIX (17.00). FTYCX has a lower initial minimum investment than VSCIX: FTYCX (1000) vs VSCIX (5000000). FTYCX annual gain was more profitable for investors over the last year : 26.02 vs. VSCIX (22.58). FTYCX return over 5 years is better than : 56.66 vs. VSCIX (35.13).
FTYCXVSCIXFTYCX / VSCIX
Total Expense Ratio1.640.035,467%
Annual Report Gross Expense Ratio1.640.035,467%
Fund Existence8 years29 years-
Gain YTD16.42314.591113%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B189B6%
Annual Yield % from dividends0.001.23-
Returns for 1 year26.0222.58115%
Returns for 3 years49.4443.44114%
Returns for 5 years56.6635.13161%
Returns for 10 yearsN/A156.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C